A metastatic breast cancer survivor shares how exercise gave her a sense of control while emphasizing why it should never be used to blame people with cancer.
|Articles|July 27, 2009
Countdown to a possible new drug approval for kidney cancer
Author(s)Melissa Weber
Advertisement
Just got word from a Genentech spokesperson that the company expects to hear by the end of this week whether the FDA will approve Avastin for metastatic kidney cancer. (Check out the
Advertisement
Related to this article
A long-term metastatic ovarian cancer survivor explains how a trifecta of hope, purpose and grace has shaped her life through years of treatment.
Six-year PERSEUS results show 81% of newly diagnosed, transplant-eligible myeloma patients had no cancer progression, with many stopping Darzalex.
A phase 3 trial found that adding Imdelltra to Imfinzi maintenance improved survival in extensive-stage small cell lung cancer, while another drug's application was pulled. Here's what patients should know.
Living with metastatic breast cancer can make Pinktober feel complicated. One patient reflects on awareness, research, loss and remembering the people behind the pink.
A leukemia survivor recalls how bonding with other patients helped his hospital stays go by faster and became a key part of his emotional healing.
Learn how nipple-sparing mastectomy, including endoscopic approaches, may help preserve appearance, reduce scarring and support breast cancer recovery.
After 17 and a half years with metastatic primary peritoneal cancer, a former hospital executive explains how an AI health agent helped her after discharge.
Advertisement
Advertisement
Trending on CURE
1
5 Years of Breast Cancer Advances: A Timeline of FDA Approvals and What They Mean for Patients
2
Radiation Oncologist Answers Top Questions About Radiation Therapy
3
10 Cancer Treatment Approvals From September 2026 and What They Mean for You
4
Beyond Pinktober: What Breast Cancer Awareness Means With Metastatic Breast Cancer
5